Literature DB >> 21068324

Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun.

Nicole Baganz1, Rebecca Horton, Kathryn Martin, Andrew Holmes, Lynette C Daws.   

Abstract

Activation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with increased extracellular serotonin (5-HT) in limbic brain regions. The mechanism through which this occurs remains unclear. One way could be via HPA axis-dependent impairment of serotonin transporter (SERT) function, the high-affinity uptake mechanism for 5-HT. Consistent with this idea, we found that 5-HT clearance rate in hippocampus was dramatically reduced in mice exposed to repeated swim, a stimulus known to activate the HPA axis. However, this phenomenon also occurred in mice lacking SERT, ruling out SERT as a mechanism. The organic cation transporter 3 (OCT3) is emerging as an important regulator of brain 5-HT. Moreover, corticosterone, which is released upon HPA axis activation, blocks 5-HT uptake by OCT3. Repeated swim produced a persistent elevation in plasma corticosterone, and, consistent with prolonged blockade by corticosterone, we found that OCT3 expression and function were reduced in these mice. Importantly, this effect of repeated swim to reduce 5-HT clearance rate was corticosterone dependent, as evidenced by its absence in adrenalectomized mice, in which plasma corticosterone levels were essentially undetectable. Behaviorally, mice subjected to repeated swim spent less time immobile in the tail suspension test than control mice, but responded similarly to SERT- and norepinephrine transporter-selective antidepressants. Together, these results show that reduced 5-HT clearance following HPA axis activation is likely mediated, at least in part, by the corticosterone-sensitive OCT3, and that drugs developed to selectively target OCT3 (unlike corticosterone) may be candidates for the development of novel antidepressant medications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068324      PMCID: PMC3064500          DOI: 10.1523/JNEUROSCI.2740-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  75 in total

1.  A suprachiasmatic nucleus generated rhythm in basal glucose concentrations.

Authors:  S E La Fleur; A Kalsbeek; J Wortel; R M Buijs
Journal:  J Neuroendocrinol       Date:  1999-08       Impact factor: 3.627

2.  Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter.

Authors:  D Gründemann; B Schechinger; G A Rappold; E Schömig
Journal:  Nat Neurosci       Date:  1998-09       Impact factor: 24.884

Review 3.  Stress and hippocampal plasticity.

Authors:  B S McEwen
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

4.  Site-dependent effects of an acute intensive exercise on extracellular 5-HT and 5-HIAA levels in rat brain.

Authors:  D Gomez-Merino; F Béquet; M Berthelot; M Chennaoui; C Y Guezennec
Journal:  Neurosci Lett       Date:  2001-03-30       Impact factor: 3.046

5.  Selective substrates for non-neuronal monoamine transporters.

Authors:  D Gründemann; G Liebich; N Kiefer; S Köster; E Schömig
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

6.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains.

Authors:  F Fernandez; V Coomans; P Mormede; F Chaouloff
Journal:  Endocr Regul       Date:  2001-09

8.  Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine.

Authors:  C Davidson; E H Ellinwood; S B Douglas; T H Lee
Journal:  J Neurosci Methods       Date:  2000-08-15       Impact factor: 2.390

9.  Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo.

Authors:  David Weinshenker; Sylvia S White; Martin A Javors; Richard D Palmiter; Patricia Szot
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

10.  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Authors:  Martina Hayer-Zillgen; Michael Brüss; Heinz Bönisch
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

View more
  31 in total

1.  Aging and stress: past hypotheses, present approaches and perspectives.

Authors:  Pedro Garrido
Journal:  Aging Dis       Date:  2011-01-28       Impact factor: 6.745

2.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

3.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

4.  Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.

Authors:  T Lee Gilman; Christina M George; Melissa Vitela; Myrna Herrera-Rosales; Mohamed S Basiouny; Wouter Koek; Lynette C Daws
Journal:  Eur J Neurosci       Date:  2018-05-24       Impact factor: 3.386

5.  Regional characteristics of histamine uptake into neonatal rat astrocytes.

Authors:  Katja Perdan-Pirkmajer; Sergej Pirkmajer; Andreja Raztresen; Mojca Krzan
Journal:  Neurochem Res       Date:  2013-04-03       Impact factor: 3.996

6.  Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.

Authors:  Britta Haenisch; Eva Drescher; Lidia Thiemer; Hu Xin; Bruno Giros; Sophie Gautron; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-18       Impact factor: 3.000

Review 7.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 8.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

9.  Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling.

Authors:  T Couroussé; A Bacq; C Belzung; B Guiard; L Balasse; F Louis; A-M Le Guisquet; A M Gardier; A H Schinkel; B Giros; S Gautron
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

10.  Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.

Authors:  Abigail G Schindler; Daniel I Messinger; Jeffrey S Smith; Haripriya Shankar; Richard M Gustin; Selena S Schattauer; Julia C Lemos; Nicholas W Chavkin; Catherine E Hagan; John F Neumaier; Charles Chavkin
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.